Apogee Therapeutics, Inc. APGE Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on assets | -27.4%-0.6pp | -30.3%+1.3pp | -36.2%-11.8pp | -32.6%-7.1pp | -26.7%— | |
| Liquidity | ||||||
| Current ratio | 32.6×+16.8× | 26.6×+8.0× | 15.9×-0.5× | 16.4×-11.3× | 15.8×-22.3× | |
| Quick ratio | 32.6×+16.8× | 26.6×+8.0× | 15.9×-0.5× | 16.4×-11.3× | 15.8×-22.3× | |
| Cash ratio | 13.7×+10.5× | 4.7×-0.3× | 3.2×-0.5× | 3.9×-8.5× | 3.2×-19.3× | |
| Leverage | ||||||
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Valuation | ||||||
| Market capitalization | $6.28B+189% | $5.16B+100% | $2.37B-28.9% | $2.54B+14.5% | $2.17B-42.0% | |
| Enterprise value | $5.84B+181% | $5.03B+106% | $2.27B-29.6% | $2.43B+26.7% | $2.08B-36.3% | |
| Earnings yield | -4.4%+5.1pp | -5%+2.1pp | -10.7%-6.3pp | -9.4%-4.0pp | -9.5%-6.7pp |
Questions, answered.
- Where do Apogee Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Apogee Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.